Submitted by Anonymous on November 13, 2017 - 3:38pm
MSK-IMPACT: Tumor and normal sequencing to guide diagnosis, treatment selection, and clinical trial enrollment
Speaker: Michael F. Berger, PhD
Associate Director, Marie-Josée and Henry R. Kravis Center for Molecular Oncology
Memorial Sloan Kettering Cancer Center
Date:
Tuesday, January 9, 2018 - 12:45pm to 1:45pm